This Is MS - More Fallout: Glaxo Halts MS Drug Trial on Tysabri Recall | Unbiased Multiple Sclerosis Research, News, and Community

Modules

· Home
· Content
· Downloads
· Encyclopedia
· FAQ
· Feedback
· Forums
· Journal
· Private Messages
· Recommend Us
· Search
· Site_Map
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links
· Your Account

Google

These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS.

Languages

Select Interface Language:

Who's Online

There are currently, 217 guest(s) and 9 member(s) that are online.

You are Anonymous user. You can register for free by clicking here

Next Step

From the creators of This is MS comes Experience Project

EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at Experience Project.

Get started by sharing your Multiple Sclerosis story.

Donations

To remain unbiased, This is MS does not accept corporate sponsorships.

Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you!

News: More Fallout: Glaxo Halts MS Drug Trial on Tysabri Recall

More of the same... Glaxo's Phase II trials of an experimental MS treatment, referred to as 683699, have been halted because the drug is considered to be in the same class as Tysabri-- an alpha-4 integrin blocker. This halt is a precautionary measure and not based on any adverse reactions seen thus far.

Glaxo maintains that the drug is chemically different than Tysabri, and likewise the drug is in pill form, versus Tysabri's monthly intravenous administration. About 400 patients had received the therapy thus far, and it was scheduled to seek approval in 2008.

"GlaxoSmithKline Plc, Europe's biggest drugmaker, said U.S. regulators suspended clinical trials of its experimental multiple sclerosis drug because it's in the same class as the recently withdrawn Tysabri medication."

Click "read more" to get the source article link...

Full Article

Please click here for the link to the full article.

Login

Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Related Links

· More about Tysabri (Antegren or Natalizumab)
· News by Administrator

Most read story about Tysabri (Antegren or Natalizumab):
Revealing Medical History of 3rd Tysabri Patient with PML

Article Rating

Average Score: 4
Votes: 1

Options

Printer Friendly

Personal Stories about millions of life experience--including multiple sclerosis support, lupus support, depression support . Built by the This is MS team.

Anonymous Confessions | Dream Dictionary
Site Map

This site does not offer medical advice. All treatment decisions should always be made with the full consent of your physician.

Visit our sister site dedicated to Inflammatory Bowel Disease: This is IBD

All logos and trademarks in this site are property of their respective owners. The comments are property of their posters, quoted articles are © referenced source, all the rest © 2002 by thisisMS.com.
PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.
Page Generation: 0.12 Seconds